Serum osteocalcin and bone mineral density at various skeletal sites: A study performed with three different assays

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 4, 1997, Pages 422-429

  Minisola, Salvatore ^a,b   Rosso, Rossana ^a   Romagnoli, Elisabetta ^a   D' Erasmo, Emilio ^a   Manfredi, Giuseppe ^a   Damiani, Carla ^a   De Antoni, Francesco ^a   Mazzuoli, Gianfranco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Istituto di Clinica Pediatrica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031126406     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90075-5     Document Type: Article

References (40)

1. Stein G, Lian J, Owen T. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 1990;4:3111-23.
2. Weinreb M, Shinar D, Rodan G. Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res 1990;5:831-42.
3. Ingram RT, Park Y-K, Clarke BL, Fitzpatrick LA. Age- and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone. Possible involvement of osteocalcin in bone remodelling. J Clin Invest 1994;93:989-97.
4. Hauschka PV, Lian JB, Gallop PM. Direct identification of the calcium-binding amino acid gamma-carboxyglutamic in the mineralized tissue. Proc Natl Acad Sci U S A 1975;72: 3925-9.
5. Price PA, Parthermore JG, Deftos LJ. New biochemical marker for bone metabolism: measurement by radioimmunoassay for gla protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 1980;66:878-83.
6. Delmas PD, Wahner HW, Mann K, Riggs BL. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone gla-protein. J Lab Clin Med 1983;102:470-6.
7. Gundberg CM, Lian JB, Gallop PM, Steinberg JJ. Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone marker. Studies in osteoporosis and Paget's disease. J Clin Endocrinol Metab 1983;57:1221-5.
8. Deftos LJ, Parthermore JG, Price PA. Changes in plasma bone gla protein during treatment of bone disease. Calcif Tissue Int 1982;34:121-4.
9. Delmas PD, Wilson DM, Mann KG, Riggs BL. Effects of renal function on plasma levels of bone gla-protein. J Clin Endocrinol Metab 1983;57:1028-30.
10. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ. Serum bone gla protein. A specific marker for bone turnover in postmenopausal osteoporosis. Lancet 1984; 1:1091-3.
11. Lian JB, Gundberg CM. Osteocalcin: biochemical considerations and clinical applications. Clin Orthop 1988;226:267-91.
12. Cole DEC, Carpenter TO, Gundberg CM. Serum osteocalcin concentrations in children with metabolic bone disease. J Pediatr 1985;106:770-6.
13. Minisola S, Scarnecchia L, Scarda A, et al. Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery. Miner Electrolyte Metab 1988;14:201-7.
14. Mazzuoli GF, Minisola S, Valtorta C, Antonelli R, Tabolli S, Bigi F. Changes in mineral content and biochemical bone markers at the menopause. Isr J Med Sci 1985;21:875-7.
15. Christiansen C, Riis BJ, Rodbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987;1:1105-8.
16. Christiansen C, Riis BJ, Rodbro P. Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteoporosis Int 1990;1:35-40.
17. Scarnecchia L, Minisola S, Pacitti MT, et al. Clinical usefulness of serum tartrate-resistant acid phosphatase activity to evaluate bone turnover. Scand J Clin Lab Invest 1991;51:517-24.
18. Minisola S, Rosso R, Romagnoli E, et al. Trabecular bone mineral density in primary hyperparathyroidism: relationship to clinical presentation and biomarkers of skeletal turnover. Bone Miner 1993;20:113-23.
19. Power MJ, Gosling JP, Fottrell PF. Radioimmunoassay of osteocalcin with polyclonal and monoclonal antibodies. Clin Chem 1989;35:1408-15.
20. Power MJ, Fottrell PF. Osteocalcin: diagnostic methods and clinical applications. Crit Rev Clin Lab Sci 1991;28:287-335.
21. Bouillon R, Vanderschueren D, Van Herck E, et al. Homologous radioimmunoassay of human osteocalcin. Clin Chem 1992;38:2055-60.
22. Jaouhari J, Schiele F, Dragacci S, et al. Avidin-biotin enzyme immunoassay of osteocalcin in serum or plasma. Clin Chem 1992;38:1968-74.
23. Monaghan DA, Power MJ, Fottrell PF. Sandwich enzyme immunoassay of osteocalcin in serum with use of an antibody against human osteocalcin. Clin Chem 1993;39:942-7.
24. Kao PC, Riggs BL, Schryver PG. Development and evaluation of an osteocalcin chemiluminoimmunoassay. Clin Chem 1993;39:1369-74.
25. Price PA, Nishimoto SK. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci U S A 1980;77:2234-8.
26. Minisola S, Carnevale V, Pacitti MT, et al. Serum osteocalcin in metabolic bone disease: what is its real significance? J Endocrinol Invest 1993;16:277-9.
27. Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Miner Res 1992;12:1389-98.
28. Minisola S, Romagnoli E, Scarnecchia L, et al. Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery. Eur J Endocrinol 1994;130:587-91.
29. Griffin MG, Rupich RC, Avioli LV, Pacifici R. A comparison of dual energy radiography measurement at the lumbar spine and proximal femur for the diagnosis of osteoporosis. J Clin Endocrinol Metab 1991;73:1164-9.
30. Delmas PD, Christiansen C, Mann KG, Price PA. Bone Gla protein (osteocalcin) assay standardization report. J Bone Miner Res 1990;5:5-11.
31. Delmas PD, Stenner D, Wahner HW, Mann KG, Riggs BL. Increase in serum bone gamma carboxyglutamic acid protein with ageing in women. J Clin Invest 1983;71:1316-21.
32. Epstein S, Poser J, Mc Clintock R, Johnston C, Bryce G, Hui S. Differences in serum bone gla protein with age and sex. Lancet 1984;1:307-10.
33. Kelly PJ, Pocock NA, Sambrook PN, Eisman JA. Age and menopause-related changes in indices of bone turnover. J Clin Endocrinol Metab 1989;69:1160-5.
34. Johansen J, Riis BJ, Delmas PD, Christiansen C. Plasma BGP: an indicator of spontaneous bone loss and of the effects of oestrogenous treatment in postmenopausal women. Eur J Clin Invest 1988;18:191-5.
35. Yasamura S, Aloia JF, Gundberg CM, et al. Serum osteocalcin and total body calcium in normal pre- and postmenopausal women and postmenopausal osteoporotic patients. J Clin Endocrinol Metab 1987;64:681-5.
36. Gertz BJ, Shao P, Hanson DA, et al. Monitoring bone resortion in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 1994;9:135-42.
37. Mazess RB, Barden HS, Eberle RW, Drue Denton M. Age changes of spine density in posterior-anterior and lateral projections in normal women. Calcif Tissue Int 1995;56:201-5.
38. Compston JE, Cooper C, Kanis JA. Bone densitometry in clinical practice. BMJ 1995;310:1507-10.
39. Masters PW, Jones RG, Purves DA, Cooper EH, Cooney JM. Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 1994;40:358-63.
40. Diaz Diego EM, Guerrero R, De La Piedra C. Six osteocalcin assays compared. Clin Chem 1994;40:2071-7.